Literature DB >> 18651644

Differences in aggressive behavior and in the mesocorticolimbic DA system between A/J and BALB/cJ mice.

Maria H Couppis1, Craig H Kennedy, Gregg D Stanwood.   

Abstract

The neurotransmitters DA and serotonin are known to be important modulators of aggression, but endogenous differences in these systems between aggressive and nonaggressive animals are poorly understood. To examine this issue, the mesocorticolimbic DA and serotonin systems of two mouse strains that differ in aggressive behavior, BALB/cJ and A/J, were analyzed using high performance liquid chromatography and quantitative receptor autoradiography. Significant differences in both serotonergic and dopaminergic systems were found between aggressive and nonaggressive mice. The nonaggressive A/J mice exhibited higher DA utilization in the nucleus accumbens and prefrontal cortex, higher D1 receptor expression in the rostral pole of the accumbens, and lower D2 receptor expression throughout the accumbens, as compared with aggressive BALB/cJ mice. Although correlative in nature, these data suggest that differences in mesocorticolimbic DA and serotonin systems may contribute to endogenous differences in aggression. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651644     DOI: 10.1002/syn.20545

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  14 in total

1.  Phenotypic instability between the near isogenic substrains BALB/cJ and BALB/cByJ.

Authors:  Laura J Sittig; Choongwon Jeong; Emily Tixier; Joe Davis; Camila M Barrios-Camacho; Abraham A Palmer
Journal:  Mamm Genome       Date:  2014-07-05       Impact factor: 2.957

2.  Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.

Authors:  Stephanie J Klenotich; Mariel P Seiglie; Matthew S McMurray; Jamie D Roitman; Daniel Le Grange; Priya Dugad; Stephanie C Dulawa
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

3.  Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status.

Authors:  Corinde E Wiers; Elizabeth A Cabrera; Dardo Tomasi; Christopher T Wong; Şükrü B Demiral; Sung Won Kim; Gene-Jack Wang; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2017-06-23       Impact factor: 7.853

4.  Nucleus accumbens dichotomically controls social dominance in male mice.

Authors:  Qiang Shan; You Hu; Shijie Chen; Yao Tian
Journal:  Neuropsychopharmacology       Date:  2021-11-08       Impact factor: 7.853

5.  A receptor-based model for dopamine-induced fMRI signal.

Authors:  Joseph B Mandeville; Christin Y M Sander; Bruce G Jenkins; Jacob M Hooker; Ciprian Catana; Wim Vanduffel; Nathaniel M Alpert; Bruce R Rosen; Marc D Normandin
Journal:  Neuroimage       Date:  2013-03-01       Impact factor: 6.556

6.  Aggression as positive reinforcement in mice under various ratio- and time-based reinforcement schedules.

Authors:  Michael E May; Craig H Kennedy
Journal:  J Exp Anal Behav       Date:  2009-03       Impact factor: 2.468

7.  Early Prevention of Severe Neurodevelopmental Behavior Disorders: An Integration.

Authors:  Stephen R Schroeder; Andrea Courtemanche
Journal:  J Ment Health Res Intellect Disabil       Date:  2012-07-02

8.  Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments.

Authors:  Bethann McLaughlin; Matthew A Buendia; Tommy P Saborido; Amy M Palubinsky; Jeannette N Stankowski; Gregg D Stanwood
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders.

Authors:  Yoshie Yamaguchi; Young-A Lee; Yukiori Goto
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

Review 10.  Developmental origins of brain disorders: roles for dopamine.

Authors:  Kelli M Money; Gregg D Stanwood
Journal:  Front Cell Neurosci       Date:  2013-12-19       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.